{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:30Z","timestamp":1781639730852,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Application research on prevention of gallstone occurrence based on intestinal flora","award":["2020BEG03004"],"award-info":[{"award-number":["2020BEG03004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Gallbladder stones (GBS) and gallbladder cancer (GBC) are prevalent gallbladder diseases that, while presenting distinct clinical manifestations, may share common regulatory mechanisms at the molecular level. This study aimed to identify and validate common differentially expressed genes (C-DEGs) in GBS and GBC through comprehensive bioinformatics analysis and experimental validation to elucidate potential molecular pathological mechanisms linking these two conditions.\u00a0<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed gene expression data from publicly available databases for GBS and GBC, identifying 94 common differentially expressed genes (C-DEGs) through differential expression analysis. Gene ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to characterize the functions and pathways associated with these genes. Furthermore, we examined the differential expression of transcription factors (TFs) in both GBS and GBC groups and experimentally validated the functions of these genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our analysis identified 94\u00a0C-DEGs, including 10 hub genes (HC-DEGs): SOCS3, GADD45B, SGK1, MYC, HBEGF, KLF10, EGF, IL6, NR4A3, and CDKN1A. GO functional analysis revealed that these genes primarily regulate smooth muscle cell proliferation, animal organ regeneration, peptidyl-tyrosine phosphorylation, epidermal growth factor-activated receptor activity, and the JAK-STAT signaling pathway. KEGG pathway analysis demonstrated their involvement in multiple cancers (bladder, endometrial, colorectal, thyroid, breast, and gastric), the FoxO signaling pathway, the JAK-STAT signaling pathway, the ErbB signaling pathway, and transcriptional dysregulation in cancer. Additionally, we identified 14 differentially expressed TFs in the GBS group and 11 in the GBC group. Four transcription factors\u2014E2F1, ETS2, EZH2, and MYC\u2014showed differential co-expression in both conditions and were jointly involved in regulating two hub genes (CDKN1A and MYC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Through comprehensive bioinformatics analysis and experimental validation, this study revealed common molecular mechanisms between GBS and GBC. We identified and validated 10 hub genes that exhibited significant differential expression in both conditions and were primarily involved in multiple cancer-related signaling pathways. Furthermore, we identified four transcription factors (E2F1, ETS2, EZH2, and MYC) showing differential co-expression in both GBS and GBC, which jointly regulated two hub genes (CDKN1A and MYC). These findings illuminate shared molecular mechanisms between GBS and GBC, providing novel insights for further investigation of their molecular pathological mechanisms and establishing an important theoretical foundation for future preventive and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12935-026-04193-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:16:39Z","timestamp":1772774199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared molecular mechanisms of common differentially expressed genes (C-DEGs) linking gallbladder stones to carcinogenesis: integrated bioinformatics and experimental validation"],"prefix":"10.1186","volume":"26","author":[{"given":"Jingzhe","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuoyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genwang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"4193_CR1","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.2147\/OTT.S262613","volume":"13","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Sun H, Wu L, Wu F, Tang W, Wang X, et al. VUp-Regulation of VCAN promotes the Proliferation, invasion and migration and serves as a biomarker in gastric cancer. Onco Targets Ther. 2020;13:8665\u201375.","journal-title":"Onco Targets Ther"},{"key":"4193_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/hortres.2017.79","volume":"4","author":"P Wu","year":"2017","unstructured":"Wu P, Wang W, Li Y, Hou X. Divergent evolutionary patterns of the MAPK cascade genes in Brassica rapa and plant phylogenetics. Hortic Res. 2017;4:17079.","journal-title":"Hortic Res"},{"key":"4193_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-021-00609-4","volume":"26","author":"T-A Xie","year":"2021","unstructured":"Xie T-A, He Z-J, Liang C, Dong H-N, Zhou J, Fan S-J, et al. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2. Eur J Med Res. 2021;26:146.","journal-title":"Eur J Med Res"},{"key":"4193_CR4","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Nucleic Acids Res"},{"key":"4193_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20:185.","journal-title":"Genome Biol"},{"key":"4193_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8755263","volume":"2022","author":"X Pang","year":"2022","unstructured":"Pang X, Wan W, Wu X, Shen Y. The novel action of miR-193b-3p\/CDK1 signaling in HCC proliferation and migration: a study based on bioinformatic analysis and experimental investigation. Int J Genomics. 2022;2022:8755263.","journal-title":"Int J Genomics"},{"key":"4193_CR7","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60\u20134.","journal-title":"Nucleic Acids Res"},{"key":"4193_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.822187","volume":"10","author":"Q Tang","year":"2022","unstructured":"Tang Q, Wang S, Di Z, Li H, Xu K, Hu X, et al. Identification and validation of a prognostic risk model based on caveolin family genes for breast cancer. Front Cell Dev Biol. 2022;10:822187.","journal-title":"Front Cell Dev Biol"},{"key":"4193_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.614773","volume":"12","author":"H-H Xu","year":"2021","unstructured":"Xu H-H, Gan J, Xu D-P, Li L, Yan W-H. Comprehensive transcriptomic analysis reveals the role of the immune checkpoint HLA-G molecule in cancers. Front Immunol. 2021;12:614773.","journal-title":"Front Immunol"},{"key":"4193_CR10","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.3892\/mmr.2017.6933","volume":"16","author":"Y-E He","year":"2017","unstructured":"He Y-E, Qiu H-X, Jiang J-B, Wu R-Z, Xiang R-L, Zhang Y-H. Microarray analysis reveals key genes and pathways in tetralogy of fallot. Mol Med Rep. 2017;16:2707\u201313.","journal-title":"Mol Med Rep"},{"key":"4193_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2021.01.003","author":"L Harris","year":"2021","unstructured":"Harris L, Rigo P, Stiehl T, Gaber ZB, Austin SHL, Masdeu MDM, et al. Coordinated changes in cellular behavior ensure the lifelong maintenance of the hippocampal stem cell population. Cell Stem Cell. 2021;28:863\u2013876.e6. https:\/\/doi.org\/10.1016\/j.stem.2021.01.003.","journal-title":"Cell Stem Cell"},{"key":"4193_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.689224","volume":"8","author":"J Yin","year":"2021","unstructured":"Yin J, Li X, Lv C, He X, Luo X, Li S, et al. Immune-related lncRNA signature for predicting the immune landscape of head and neck squamous cell carcinoma. Front Mol Biosci. 2021;8:689224.","journal-title":"Front Mol Biosci"},{"key":"4193_CR13","doi-asserted-by":"publisher","first-page":"24528","DOI":"10.1074\/jbc.M113.484014","volume":"288","author":"DC Berry","year":"2013","unstructured":"Berry DC, Jacobs H, Marwarha G, Gely-Pernot A, O\u2019Byrne SM, DeSantis D, et al. The STRA6 receptor is essential for retinol-binding protein-induced insulin resistance but not for maintaining vitamin A homeostasis in tissues other than the eye. J Biol Chem. 2013;288:24528\u201339.","journal-title":"J Biol Chem"},{"key":"4193_CR14","first-page":"349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349\u201364.","journal-title":"CA Cancer J Clin"},{"key":"4193_CR15","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","volume":"23","author":"A Sharma","year":"2017","unstructured":"Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update. World J Gastroenterol. 2017;23:3978\u201398.","journal-title":"World J Gastroenterol"},{"key":"4193_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872\u20136.","journal-title":"Nat Genet"},{"key":"4193_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6:172\u201387.","journal-title":"Gut Liver"},{"key":"4193_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1470-2045(17)30167-5","volume":"18","author":"S Mhatre","year":"2017","unstructured":"Mhatre S, Wang Z, Nagrani R, Badwe R, Chiplunkar S, Mittal B, et al. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study. Lancet Oncol. 2017;18:535\u201344.","journal-title":"Lancet Oncol"},{"key":"4193_CR19","doi-asserted-by":"crossref","unstructured":"Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder cancer: an update. Mutat Res. 2019;816\u2013818:111674.","DOI":"10.1016\/j.mrfmmm.2019.111674"},{"key":"4193_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00823","volume":"10","author":"JH Wang","year":"2020","unstructured":"Wang JH, Xu C, Cheng Q, Zhao JM, Wu SX, Li W, et al. RNA sequencing revealed signals of evolution from gallbladder stone to gallbladder carcinoma. Front Oncol. 2020;10:823.","journal-title":"Front Oncol"},{"key":"4193_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167\u201376.","journal-title":"Lancet Oncol"},{"key":"4193_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/modpathol.2011.68","volume":"24","author":"JC Roa","year":"2011","unstructured":"Roa JC, Tapia O, Cakir A, Basturk O, Dursun N, Akdemir D, et al. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol. 2011;24:1069\u201378.","journal-title":"Mod Pathol"},{"key":"4193_CR23","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109.","journal-title":"Clin Epidemiol"},{"key":"4193_CR24","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1002\/cam4.915","volume":"5","author":"J Koshiol","year":"2016","unstructured":"Koshiol J, Wozniak A, Cook P, Dhillon PK, Duell EJ, Goedert JJ, et al. Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis. Cancer Med. 2016;5:3310\u201335.","journal-title":"Cancer Med"},{"key":"4193_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00491-3","volume":"7","author":"ZQ Cai","year":"2017","unstructured":"Cai ZQ, Guo P, Si SB, Geng ZM, Chen C, Cong LL. Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network. Sci Rep. 2017;7:293.","journal-title":"Sci Rep"},{"key":"4193_CR26","first-page":"1348","volume":"8","author":"WC Huang","year":"2020","unstructured":"Huang WC, Liang LB, Huang WH, Tan LJ, Zhang QY, Long N, et al. Identification of key genes implicated in the transformation of gallbladder adenoma to carcinoma using bioinformatics analysis. World J Clin Cases. 2020;8:1348\u201363.","journal-title":"World J Clin Cases"},{"key":"4193_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/jso.20530","volume":"93","author":"S Kumar","year":"2006","unstructured":"Kumar S, Kumar S, Kumar S. Infection as a risk factor for gallbladder cancer. J Surg Oncol. 2006;93:633\u20139.","journal-title":"J Surg Oncol"},{"key":"4193_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","volume":"15","author":"D Malka","year":"2014","unstructured":"Malka D, Cervera P, Foulon S, Trarbach T, de la Fouchardi\u00e8re C, Boucher E, et al. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial. Lancet Oncol. 2014;15:819\u201328.","journal-title":"Lancet Oncol"},{"key":"4193_CR29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381.","journal-title":"N Engl J Med"},{"key":"4193_CR30","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/ijc.31916","volume":"144","author":"P Iyer","year":"2019","unstructured":"Iyer P, Shrikhande SV, Ranjan M, Joshi A, Gardi N, Prasad R, et al. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer. Int J Cancer. 2019;144:2008\u201319.","journal-title":"Int J Cancer"},{"key":"4193_CR31","first-page":"801","volume":"16","author":"N Kumar","year":"2020","unstructured":"Kumar N, Farhana A, Mirani N, Rehman A, Khan MA, Kumar N, et al. Epidermal growth factor receptor expression in carcinoma gallbladder: a prospective study in Indian scenario. J Cancer Res Ther. 2020;16:801\u20135.","journal-title":"J Cancer Res Ther"},{"key":"4193_CR32","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-05-1692","volume":"12","author":"F Leone","year":"2006","unstructured":"Leone F, Cavalloni G, Pignochino Y, Sarotto I, Ferraris R, Piacibello W, et al. Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin Cancer Res. 2006;12:1680\u20135.","journal-title":"Clin Cancer Res"},{"key":"4193_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7150\/ijms.5.285","volume":"5","author":"M Kaufman","year":"2008","unstructured":"Kaufman M, Mehrotra B, Limaye S, White S, Fuchs A, Lebowicz Y, et al. EGFR expression in gallbladder carcinoma in North America. Int J Med Sci. 2008;5:285\u201391.","journal-title":"Int J Med Sci"},{"key":"4193_CR34","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/jgh.12505","volume":"29","author":"YT Chang","year":"2014","unstructured":"Chang YT, Chang MC, Huang KW, Tung CC, Hsu C, Wong JM. Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. J Gastroenterol Hepatol. 2014;29:1119\u201325.","journal-title":"J Gastroenterol Hepatol"},{"key":"4193_CR35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0344-0338(11)80652-7","volume":"191","author":"CS Lee","year":"1995","unstructured":"Lee CS, Pirdas A. Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours. Pathol Res Pract. 1995;191:1087\u201391.","journal-title":"Pathol Res Pract"},{"key":"4193_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-631","volume":"10","author":"Y Pignochino","year":"2010","unstructured":"Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G, et al. Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer. 2010;10:631.","journal-title":"BMC Cancer"},{"key":"4193_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2013.08.034","volume":"345","author":"Y Li","year":"2014","unstructured":"Li Y, Zhang J, Ma H. Chronic inflammation and gallbladder cancer. Cancer Lett. 2014;345:242\u20138.","journal-title":"Cancer Lett"},{"key":"4193_CR38","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.3390\/ijms23137028","volume":"23","author":"K Oda","year":"2022","unstructured":"Oda K, Hamanaka H, Itoh D, Yamashita A, Kajioka S, Fukuda D, et al. IL-6-Dependent activation of oncogenic STAT3 in gallbladder cancer. Int J Mol Sci. 2022;23:7028.","journal-title":"Int J Mol Sci"},{"key":"4193_CR39","doi-asserted-by":"publisher","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","volume":"10","author":"S Rose-John","year":"2018","unstructured":"Rose-John S. Interleukin-6 family cytokines. Cold Spring Harb Perspect Biol. 2018;10:a028415.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4193_CR40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/jcm10071424","volume":"10","author":"F Kleinegger","year":"2021","unstructured":"Kleinegger F, Hofer E, Wodlej C, Golob-Schwarzl N, Birkl-Toeglhofer AM, Stallinger A, et al. IL-6 Receptor-alpha expression on tumor cells is an independent prognostic factor in gallbladder cancer. J Clin Med. 2021;10:1424.","journal-title":"J Clin Med"},{"issue":"9","key":"4193_CR41","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1158\/0008-5472.CAN-16-2589","volume":"77","author":"VK Mishra","year":"2017","unstructured":"Mishra VK, Subramaniam M, Kari V, Pitel KS, Baumgart SJ, Naylor RM, Nagarajan S, Wegwitz F, Ellenrieder V, Hawse JR, Johnsen SA. Kruppel-like transcription factor KLF10 suppresses TGFbeta-induced epithelial-to-mesenchymal transition via a negative feedback mechanism. Cancer Res. 2017;77(9):2387\u2013400.","journal-title":"Cancer Res"},{"key":"4193_CR42","first-page":"1126","volume":"42","author":"S Fumino","year":"2007","unstructured":"Fumino S, Iwai N, Deguchi E, Shimatake H, Iwai M, Ono S, et al. Increased expression of cyclooxygenase-2 in hypoplastic and hyperplastic gallbladders of patients with anomalous arrangement of the pancreaticobiliary duct. J Pediatr Surg. 2007;42:1126\u201330.","journal-title":"J Pediatr Surg"},{"key":"4193_CR43","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2353\/ajpath.2006.060146","volume":"169","author":"L Finzi","year":"2006","unstructured":"Finzi L, Barbu V, Burgel PR, Mergey M, Kirkwood KS, Wick EC, et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. Am J Pathol. 2006;169:2031\u201341.","journal-title":"Am J Pathol"},{"key":"4193_CR44","first-page":"1251","volume":"22","author":"N Kumar","year":"2021","unstructured":"Kumar N, Dhar A, Mishra N, Nigam M, Vaidya A, Priyadarshi S, et al. Expression of EGFR and PTEN in gallbladder carcinoma and role of EGFR in proliferation and invasion of gallbladder carcinoma. Asian Pac J Cancer Prev. 2021;22:1251\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4193_CR45","first-page":"51","volume":"31","author":"LX Fu","year":"2017","unstructured":"Fu LX, Lian Q, Pan J, Xu Z, Zhou TM, Ye B. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2\/STAT3 signaling. J Biol Regul Homeost Agents. 2017;31:51\u20138.","journal-title":"J Biol Regul Homeost Agents"},{"key":"4193_CR46","first-page":"1021","volume":"40","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Sun L, Sun Y, Wang J, Ma L, Lu L, et al. Single-cell transcriptomics reveals clonal expansion and immunosuppression in gallbladder cancer microenvironment. Cancer Cell. 2022;40:1021\u201340.","journal-title":"Cancer Cell"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04193-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04193-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:28:21Z","timestamp":1781638101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04193-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04193-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics statement confirms approval from the Ethics Committee of the General Hospital of Ningxia Medical University, under approval number NXMU-2020-ETHICS-0043. The consent procedures for the use of human tissue are as follows: all human tissue samples were collected only after obtaining prior written informed consent from the patients or their legal representatives. This informed consent process was conducted by trained medical staff who thoroughly explained the study\u2019s purpose, potential risks and benefits, and the rights of the participants. All procedures were performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.\u00a0All authors consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"All authors have given consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"165"}}